Klaria Pharma Holding AB (publ.) (STO:KLAR)
0.7880
+0.0080 (1.03%)
Jul 24, 2026, 5:24 PM CET
STO:KLAR Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.26 | 0.34 | 0.6 | 1.25 | 16.76 | 25.49 |
Cash & Short-Term Investments | 0.26 | 0.34 | 0.6 | 1.25 | 16.76 | 25.49 |
Cash Growth | -82.89% | -42.81% | -52.04% | -92.56% | -34.25% | -18.43% |
Accounts Receivable | 2.23 | 0 | 0.36 | 0.53 | 2.21 | 0 |
Other Receivables | - | 0.73 | 0.92 | 1.35 | 21.27 | 1.76 |
Total Trade Receivables | 2.23 | 2.05 | 2.26 | 3.22 | 24 | 2.31 |
Other Current Assets | - | 1.32 | 0.98 | 1.34 | 0.52 | 0.55 |
Total Current Assets | 2.49 | 2.39 | 2.85 | 4.47 | 40.76 | 27.8 |
Net Property, Plant & Equipment | 0.37 | 0.59 | 1.47 | 0.37 | 1.07 | 1.72 |
Other Intangible Assets | 27.15 | 29.55 | 52.95 | 68.11 | 78.45 | 88.79 |
Total Assets | 30.01 | 32.53 | 57.27 | 72.95 | 120.27 | 118.31 |
Accounts Payable | - | 9.16 | 7.01 | 5.33 | 9.65 | 8.63 |
Accrued Expenses | - | 9.09 | 21.8 | 6.03 | 6.25 | 6.25 |
Short-Term Debt | - | 14.65 | 21.58 | 18.93 | 16.07 | 30.05 |
Current Portion of Leases | - | 0.65 | 0.87 | 0.34 | 0.68 | 0.66 |
Other Current Liabilities | - | 1.34 | 2.08 | 1.18 | 11.21 | 2.29 |
Total Current Liabilities | 40.92 | 34.88 | 53.34 | 31.81 | 43.85 | 47.87 |
Long-Term Debt | - | 9.7 | 0 | - | - | - |
Long-Term Leases | - | 0 | 0.62 | 0 | 0.34 | 1.02 |
Total Long-Term Liabilities | 9.7 | 9.7 | 0.62 | 0 | 0.34 | 1.02 |
Total Liabilities | 50.62 | 44.58 | 53.96 | 31.81 | 44.19 | 48.89 |
Common Stock | - | 4.1 | 2.41 | 1.78 | 1.31 | 0.86 |
Additional Paid-in Capital | - | 31.12 | 48.77 | 279.07 | 173.06 | 238.44 |
Accumulated Other Comprehensive Income | - | -0.21 | -0.12 | 0.06 | -0.02 | -0.02 |
Retained Earnings | - | -47.06 | -47.75 | -239.65 | -98.27 | -169.87 |
Total Common Shareholders' Equity | - | -12.05 | 3.31 | 41.13 | 76.08 | 69.41 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity | -20.61 | -12.04 | 3.31 | 41.13 | 76.08 | 69.42 |
Total Liabilities & Equity | 30.01 | 32.53 | 57.27 | 72.95 | 120.27 | 118.31 |
Total Debt | - | 25 | 23.07 | 19.28 | 17.09 | 31.72 |
Net Cash (Debt) | 0.26 | -24.65 | -22.47 | -18.03 | -0.32 | -6.23 |
Net Cash Growth | -82.89% | - | - | - | - | - |
Net Cash Per Share | 0.00 | -0.13 | -0.18 | -0.18 | -0.01 | -0.12 |
Book Value | - | -12.05 | 3.31 | 41.13 | 76.08 | 69.41 |
Book Value Per Share | - | -0.06 | 0.03 | 0.41 | 1.31 | 1.34 |
Tangible Book Value | -27.15 | -41.59 | -49.64 | -26.97 | -2.37 | -19.37 |
Tangible Book Value Per Share | -0.13 | -0.22 | -0.40 | -0.27 | -0.04 | -0.37 |